Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Acura Pharmaceuticals Inc ACUR

Healthcare Drug Manufacturers - Specialty & Generic
Acura Pharmaceuticals, Inc. is a drug delivery company engaged in the research, development, and commercialization of technologies and products to address the safe use of medications. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the... see more

Recent & Breaking News (GREY:ACUR)

Acura Pharmaceuticals Announces Top-Line Results of a Clinical Study Assessing Abuse Liability

Marketwired August 26, 2013

Acura Pharmaceuticals Announces Second Quarter 2013 Financial Results

Marketwired August 1, 2013

Acura Pharmaceuticals to Host Second Quarter 2013 Financial Results Conference Call on August 2, 2013

Marketwired July 26, 2013

Acura Pharmaceuticals to Develop Improved NEXAFED(R)

Marketwired July 15, 2013

Technical Scrutiny: VIVUS, Sanofi, DENTSPLY, and Acura Pharma

PR Newswire July 8, 2013

Market Expansion, Strong Sales, Regulatory Filings, and FDA Approvals - Research Report on Thermo Fisher, BioMarin, The Medicines Company, Acura Pharmaceuticals, and Endologix

PR Newswire July 4, 2013

Five Star Equities Issues New Research Reports on ACUR, ELGX, INSM and NWSA

Accesswire July 2, 2013

Acura Pharmaceuticals Provides Update on Partnership With Pfizer

Marketwired July 1, 2013

Pre-Market Analysis on VVUS, SNY, XRAY, and ACUR

Accesswire June 4, 2013

Analysis Reports On Active Stocks: (NASDAQ: ACUR), (NYSE: SMFG)

Accesswire April 25, 2013

Acura Pharmaceuticals to Host First Quarter 2013 Financial Results Conference Call on May 3, 2013

Marketwired April 22, 2013

InvestorsGuru.com 41 Filtered Mid-Day Market Movers Recap

Investors Guru April 21, 2013

Weak Earnings and Oil Falling Push Market Lower as Apple Falls to One Year Low

PR Newswire April 18, 2013

Free Research Reports on ACUR, ALKS, INWK and SCSS Issued by the Bedford Report

Marketwired April 18, 2013

Acura Pharmaceuticals Awarded U.S. Patent for Abuse Deterrent Drug Formulations

Marketwired April 4, 2013

Health Management Associates, Community Health Systems, Elan Corp., and Acura Pharma Under StockCall's Microscope

PR Newswire March 22, 2013

Acura Pharmaceuticals' Universal Shelf Registration Statement Declared Effective

Marketwired March 15, 2013

U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous

Marketwired March 14, 2013

Pharma Company Eliminates Labs (ACUR) - PFE, ELN, VRX

Accesswire March 6, 2013

MGIC Investment Corp. Rallies after Upgrade from Barclays

Accesswire March 6, 2013